Related Experiment Video

Updated: Apr 15, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.0K

Monitor cancer progression without surgery, meet the technique's inventor

Mohammad Haris, Gemma Westcott

    Future Oncology (London, England)
    |April 3, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    MRISidra Medical and Research Centercancercreatine kinasepatentsurgery

    More Related Videos

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
    04:43

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

    Published on: February 27, 2020

    7.5K
    Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
    05:11

    Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

    Published on: May 10, 2024

    2.0K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
    08:55

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

    Published on: November 2, 2014

    13.0K
    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
    04:43

    Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

    Published on: February 27, 2020

    7.5K
    Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
    05:11

    Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

    Published on: May 10, 2024

    2.0K

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    8.0K
    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    8.0K
    Tumor Progression02:07

    Tumor Progression

    3.6K
    3.6K
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    853
    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    853

    Articles linked to this work by shared authors, journal, and citation graph.

    Geographic heterogeneity in outcomes of intravascular ultrasound-guided vs angiography-guided percutaneous coronary intervention: a meta-analysis of randomized trials.

    European heart journal·2026

    Detection of Lipid-Mediated Diffused Pathological Changes in Multiple Sclerosis.

    Research square·2026

    Chronic obstructive pulmonary disease and risk of incident cardiovascular disease, chronic kidney disease, and death: a systematic review and meta-analysis.

    EClinicalMedicine·2026

    Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records.

    Circulation·2026

    Scalable risk stratification of undiagnosed heart failure using routine health data and its association with imaging phenotypes and outcomes.

    Scientific reports·2026

    An imaging biomarker to detect non-glucogenic shift in brain energy metabolism in Alzheimer's disease.

    Journal of translational medicine·2026

    Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma.

    Future oncology (London, England)·2026

    Treatment patterns after first-line abemaciclib therapy in patients with HR+, HER2- metastatic breast cancer in Japan.

    Future oncology (London, England)·2026

    A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma.

    Future oncology (London, England)·2026

    Persistence and adherence to tepotinib in patients with metastatic non-small cell lung cancer: a real-world evidence study including dose reductions.

    Future oncology (London, England)·2026

    DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.

    Future oncology (London, England)·2026

    The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror?

    Future oncology (London, England)·2026

    Microneedle-mediated intelligent combination delivery for hair regeneration: A comprehensive review of technologies, mechanistic evidence, and translational prospects.

    Materials today. Bio·2026

    Real-world effectiveness and safety of tenofovir amibufenamide in treatment-naïve chronic hepatitis B: a 48-week retrospective cohort study.

    Frontiers in medicine·2026

    Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

    Haematologica·2026

    Cutaneous Toxicities of Anti-GPRC5D Bispecific Antibodies for Multiple Myeloma: Retrospective Study.

    The Journal of dermatology·2026

    Development of a Recombinant Adeno-Associated Virus Vector for Human T Lymphocyte- and Natural Killer Cell-Targeted Gene Therapy.

    Human gene therapy·2026

    How to apply artificial intelligence (AI) to facilitate and enhance MASH trials.

    Hepatology international·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us